Associations of bisphenol and phthalate exposure and anti-Müllerian hormone levels in women of reproductive age

被引:0
作者
Blaauwendraad, Sophia M. [1 ,2 ]
Dykgraaf, Ramon H. M. [3 ]
Gaillard, Romy [1 ,2 ]
Liu, Mengling [4 ,5 ]
Laven, Joop S. [3 ]
Jaddoe, Vincent W. V. [1 ,2 ]
Trasande, Leonardo [4 ,5 ]
机构
[1] Univ Med Ctr, Erasmus Med Ctr MC, Generat Study Grp R, Rotterdam, Netherlands
[2] Univ Med Ctr, Dept Pediat, Erasmus MC, Rotterdam, Netherlands
[3] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands
[4] NYU, Dept Environm Med, Sch Med, New York, NY USA
[5] NYU, Coll Global Publ Hlth, New York, NY USA
关键词
Bisphenols; Phthalates; anti-M & uuml; llerian hormone; Ovarian reserve; ANTI-MULLERIAN HORMONE; OVARIAN RESERVE; METABOLITES; COHORT;
D O I
10.1016/j.eclinm.2024.102734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In women, exposure to endocrine disrupting chemicals might accelerate the depletion of the ovarian reserve and might be associated with accelerative reproductive aging and fertility. We examined the longitudinal associations of exposure to bisphenols and phthalates with anti-M & uuml;llerian hormone concentrations. Methods Pregnant women of 18 years or older that resided in Rotterdam between 2002 and 2006 were eligible for participation in this longitudinal prospective cohort study. We measured urinary bisphenol and phthalate concentration at three time-points in pregnancy among 1405 women, of whom 1322 women had serum Anti-M & uuml;llerian Hormone (AMH) measurements 6 and/or 9 years postpartum. We performed linear regression models to assess the association of urinary bisphenol and phthalate metabolites with AMH after 6 and 9 years, and linear mixedeffect model to assess the association with AMH over time. Models were adjusted for sociodemographic and lifestyle factors. Findings In our multivariable linear regression models we observed associations of higher urinary pregnancyaveraged mono-isobutyl phthalate (mIBP), mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP), and monobenzyl phthalate (mBzBP) with lower serum AMH after both 6 and 9 years. However, these associations did not remain after adjustment for multiple testing. No signi fi cant associations of bisphenol A with AMH were present in our study sample. In our linear mixed-effects models, higher mIBP, mono-(2-ethyl-5-hydroxyhexyl) phthalate (mEHHP), mEOHP, and mBzBP were associated with lower overall AMH levels (differences - 0.07 (95% CI - 0.13, - 0.02), - 0.09 ( - 0.15, - 0.02), - 0.08 (95% CI - 0.14, - 0.02), and - 0.08 ( - 0.13, - 0.03) mu g/L per doubling in mIBP, mEHHP, mEOHP, and mBzBP respectively) (all False Discovery Rate adjusted p-values < 0.05). Interpretation We identify decreases in indices of ovarian reserve in relationship to prenatal phthalate exposures. Studies are needed replicating our results among large multi-ethnic non-pregnant populations and assessing transgenerational effects of exposure on ovarian reserve. Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Determination of anti-Müllerian hormone levels in blood and urine in fertile cats
    Kaya, Semra
    Tasci, Serap Koral
    Demir, Murat Can
    Karadag, Muhammet Ali
    Kumcu, Merve Sena
    Kacar, Cihan
    Ermutlu, Dilem Guelece
    Kuru, Mushap
    THERIOGENOLOGY, 2024, 224 : 102 - 106
  • [22] Serum anti-Müllerian hormone is an indirect predictor of ovarian reserve in domestic cats
    Chumsri, Sittat
    Suwimonteerabutr, Junpen
    Sirisawadi, Sujin
    Thongphakdee, Ampika
    Holst, Bodil Strom
    Chatdarong, Kaywalee
    THERIOGENOLOGY, 2024, 226 : 151 - 157
  • [23] The role of anti-Müllerian hormone (AMH) in reproductive physiology and assisted reproduction
    Legakis, I
    Psathas, P.
    Kostaras, K.
    Chrousos, G.
    ARCHIVES OF HELLENIC MEDICINE, 2024, 41 (01): : 17 - 24
  • [24] The Relationship Between Anti-Müllerian Hormone and Body Composition Components in Patients With Polycystic Ovary Syndrome of Reproductive Age
    Li, Xue
    Tang, Qingtao
    Feng, Yaru
    Zhang, Yanfang
    Tian, Wenyan
    Zhang, Huiying
    REPRODUCTIVE SCIENCES, 2024, 31 (09) : 2843 - 2848
  • [25] Anti-Müllerian Hormone: Current Understanding and Clinical Use
    Catherine E. Gordon
    Elena Yanushpolsky
    Current Obstetrics and Gynecology Reports, 2021, 10 : 61 - 70
  • [26] Anti-Müllerian hormone (ovarian reserve) in rheumatoid arthritis patients: correlation with disease activity
    Israel, Traez
    Saleh, Hala Abdulhady
    Ahmed, Sahar Fathi
    Gergius, Youssy Saeed Eshak
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [27] Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma
    Havlinova, Barbora
    Souckova, Ilona
    Koprivova, Katerina
    Dolezal, Jiri
    BMC RESEARCH NOTES, 2024, 17 (01)
  • [28] Anti-Müllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatments
    Reis, Ana Braga
    Leal, Carla
    Barreiro, Marcia
    Tome, Antonio
    Vale-Fernandes, Emidio
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2024, 28 (04): : 597 - 603
  • [29] Laparoscopically confirmed endometriosis and anti-Müllerian hormone levels: Findings from the Nurses' Health Study II
    Farland, Leslie V.
    Valenti, Michelle
    Degnan III, William J.
    Bertone-Johnson, Elizabeth R.
    Harris, Holly R.
    Divasta, Amy D.
    Rexrode, Kathryn M.
    Eliassen, Heather
    Missmer, Stacey A.
    MATURITAS, 2024, 183
  • [30] Association between anti-Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan
    Miyake, Natsuki
    Osuka, Satoko
    Ohsawa, Isao
    Tonoike, Takashi
    Uno, Tomoko
    Tsuzuki, Kazuo
    Sonehara, Reina
    Muraoka, Ayako
    Nakamura, Tomoko
    Goto, Maki
    Iwase, Akira
    Kajiyama, Hiroaki
    REPRODUCTIVE MEDICINE AND BIOLOGY, 2024, 23 (01)